Slow Return China
Sort by
145 items
-
World - Financial Times
China’s WuXi explores sale of pharma units as US restrictions loom
Drugmakers have been targeted on national security grounds and could lose customers if Congress passes Biosecure Act3 days ago - China -
World - Financial Times
Retail investors can sustain China’s market bounce
Beijing’s stimulus efforts may not be enough to win over battered foreign investors3 days ago - China -